SAN DIEGO and PENNINGTON, N.J., Nov.
20, 2018 /PRNewswire/ -- OncoSec Medical Incorporated
(OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer
immunotherapies, today announced that Daniel J. O'Connor, President and Chief
Executive Officer of OncoSec, will present at the Piper Jaffray
30th Annual Healthcare Conference on Wednesday, November 28, 2018 at 11:30 a.m. ET in New
York City.
A live audio webcast of the presentation will be available on
the Investors section of OncoSec's website at ir.oncosec.com, where
it will be archived for approximately 30 days.
About OncoSec Medical Incorporated
OncoSec is a clinical-stage biotechnology company focused on
developing cytokine-based intratumoral immunotherapies to stimulate
the body's immune system to target and attack cancer.
OncoSec's lead immunotherapy platform – TAVOTM
(tavokinogene telseplasmid) – enables the intratumoral delivery of
DNA-based interleukin-12 (IL-12), a naturally occurring protein
with immune-stimulating functions. The technology, which employs
electroporation, is designed to produce a controlled, localized
expression of IL-12 in the tumor microenvironment, enabling the
immune system to target and attack tumors throughout the body.
OncoSec has built a deep and diverse clinical pipeline utilizing
TAVOTM as a potential treatment for multiple cancer
indications either as a monotherapy or in combination with leading
checkpoint inhibitors; with the latter potentially enabling OncoSec
to address a great unmet medical need in oncology: anti-PD-1
non-responders. Results from recently completed clinical
studies of TAVOTM have demonstrated a local immune
response, and subsequently, a systemic effect as either a
monotherapy or combination treatment approach. In addition to
TAVOTM, OncoSec is identifying and developing new
DNA-encoded therapeutic candidates and tumor indications for use
with its ImmunoPulse® platform. For more information, please visit
www.oncosec.com.
CONTACT
Investor Relations:
Will O'Connor
Stern Investor Relations
Phone: (212) 362-1200
will@sternir.com
Media Relations:
Michael Lampe
Scient Public Relations
Phone: (484) 575-5040
michael@scientpr.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/oncosec-to-present-at-piper-jaffray-30th-annual-healthcare-conference-300753476.html
SOURCE OncoSec Medical Incorporated